Press Release

The global diabetes supplements market was valued at USD 571.1 Mn in 2021. The market is projected to grow USD 854.7 Mn in 2030, at a CAGR of 5.5%.

Regulatory agencies such as the United States Food and Drug Administration (USFDA) have taken numerous steps to ensure that only high-quality and safe dietary and food supplements are marketed in the market, promoting the usage of dietary supplements among consumers. Furthermore, during the forecast years, the increasing use of clean-labeled, safe, and organic ingredients in the production of food nutritive additives is expected to boost market demand for these supplements.

Consumers are becoming more aware of preventative healthcare measures as the prevalence of age and lifestyle-related disorders rises, and hence are gravitating toward health-beneficial items such as food additives, which is predicted to drive the global market. The industry's global growth is being boosted by increased innovation from both large and small market participants. For example, in March 2018, the GHT firms announced the debut of a new vegan nutritives product line. The new products are being developed to suit the growing demand for animal-free, plant-based weight-loss products.

The type-2 segment is expected to dominate the market share of global diabetes supplements market owing to the rising incidence among geriatric population specially in women. The vitamins range segment is expected to dominate the market share of global diabetes supplements market owing to the ability to increase the cellular reuptake of glucose in the blood makes it a main element in diabetic supplements. Vitamin supplements, which come in the form of multivitamin tablets, powders, and liquids, are becoming increasingly popular among prediabetic and diabetic patients. The tablets are expected to dominate the market share of global diabetes supplements market owing to its cost-effectiveness and ease of packaging along with longer shelf life and is easy to dissolve. The hospital pharmacies segment is expected to dominate the market share of global diabetes supplements market owing to the huge availability and consumer preference.

North America region is expected to dominate the market share of global diabetes supplements market owing to because of the growing geriatric population, advancements in the pharmaceutical sector, and an increase in the number of diabetic individuals The market is growing as a result of rising R&D investments in diabetic supplements. North American market participants are focused on a variety of techniques to improve their market position.

KEY INDUSTRY DEVELOPMENTS:

January 2022- Novo Nordisk launched anti-diabetes pill semaglutide in India for treatment of type 2 diabetes.

February 2020- Valbiotis made a strategic partnership by signing an agreement with Nestlé Health Science for the development and worldwide commercialization of TOTUM-63.

Read More Details On This Report: https://extrapolate.com/Healthcare-Medical-Devices-Biotechnology/diabetes-supplements-market/25779